Allscripts (MDRX) Reports In-Line Q2 EPS

Allscripts (NASDAQ: MDRX) reported Q2 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter came in at $428 million versus the consensus estimate of $425 million.

For earnings history and earnings-related data on Allscripts (MDRX) click here.

You May Also Be Interested In

• Gloo Holdings, Inc. (GLOO) Reports Q1 Loss of $0.21/sh, Updates Guidance
• Oracle (ORCL) PT Raised to $240 at BofA Securities
• Optical Cable Corp. (OCC) Reports Q2 EPS of $0.12